A Safety and Efficacy Study of Refresh Optive® Gel Drops in Patients With Dry Eye Disease

Study Identifier
11193X-001
CT.gov Identifier
NCT02280473
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact

844-663-3742 or [email protected]

Study Complete

Study Details

Medical Condition
  • Dry Eye
    • Study Drug
  • Refresh Optive® Gel Drops
  • REFRESH LIQUIGEL®
    • Phase
    Phase 3
    Sex
    Female & Male
    Age
    18+ years
    Inclusion and Exclusion Criteria
    Inclusion Criteria:
    * Current use of an artificial tear product * Visual acuity of at least 20/32 (while wearing glasses, if necessary).
    Exclusion Criteria:
    * Use of contact lenses in the last 3 months, or anticipated use of contact lenses during the study * Cataract surgery, laser-assisted in situ keratomileusis \[LASIK\], or photorefractive keratectomy, within the last 6 months * Current eye infection or inflammation

    Protocol Summary

    This study will evaluate the safety and efficacy o fRefresh Optive® Gel Drops in patients with dry eye disease.

    Study Locations

    Location
    Status
    Location
    North Bay Eye Associates
    Petaluma, California, United States, 94954
    Status
    Not applicable
    Location
    Eric M. White, OD, Inc.
    San Diego, California, United States, 92123
    Status
    Not applicable
    Location
    Eye Center Northeast
    Bangor, Maine, United States, 04401
    Status
    Not applicable
    Location
    Moyes Eye Center, PC
    Kansas City, Missouri, United States, 64154
    Status
    Not applicable
    Location
    Ophthalmology Associates
    St Louis, Missouri, United States, 63131
    Status
    Not applicable
    Location
    Comprehensive Eye Care, Ltd.
    Washington, Missouri, United States, 63090
    Status
    Not applicable
    Showing {first} - {last} of {total} Results